The Use of Rivaroxaban in Perioperative Period of Pulmonary Vein Antrum Isolation in Patients With Paroxysmal Atrial Fibrillation

Results of an observational study. devoted to prevention of thromboembolic complications in patients with atrial fibrillation undergoing catheter pulmonary vein atrium isolation are discussed. Patients (n= 199) were divided into two comparable groups depending on the anticoagulant (rivaroxaban or wa...

Full description

Saved in:
Bibliographic Details
Published in:Kardiologiia Vol. 55; no. 4; p. 36
Main Authors: Belikov, E A, Davtyan, K V, Tkacheva, O N, Boytsov, S A, Mazygula, E P, Shabanova, T N, Molodtsov, M S, Kharlap, M S, Serdyuk, S E
Format: Journal Article
Language:Russian
Published: Russia (Federation) 01-01-2015
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Results of an observational study. devoted to prevention of thromboembolic complications in patients with atrial fibrillation undergoing catheter pulmonary vein atrium isolation are discussed. Patients (n= 199) were divided into two comparable groups depending on the anticoagulant (rivaroxaban or warfarin) used. Clinical thromboembolic and/or hemorrhagic complications as well as rate of development of asymptomatic cerebral thromboembolisms in various periods after procedure were assessed. Main conclusion: rivaroxaban was not inferior to warfarin for thromboprophylaxis in patients with atrial fibrillation undergoing catheter pulmonary vein antrum isolation.
ISSN:0022-9040
DOI:10.18565/cardio.2015.4.36-40